Prothena (PRTA) Reports Q4 Loss, Misses Revenue Estimates

Prothena (PRTA) came out with a quarterly loss of $1.08 per share versus the Zacks Consensus Estimate of a loss of$ 1.02. This compares to loss of $1.26 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -5.88%. A quarter ago, it was expected that this drug developer would post a loss of$ 1.18 per share when it actually produced a loss of $1.10, delivering a surprise of 6.78%.Over the last four quarters, the company has surpassed ...